We are live on ! Find out more
GSEP

Golden State Equity Partners Portfolio holdings

AUM $37.1M
1-Year Est. Return 20.75%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+20.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$190M
AUM Growth
-$290M
Cap. Flow
-$305M
Cap. Flow %
-160.56%
Top 10 Hldgs %
31.39%
Holding
918
New
505
Increased
48
Reduced
253
Closed
104

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$27.9M
2
AAPL icon
Apple
AAPL
+$23.4M
3
MSFT icon
Microsoft
MSFT
+$14.9M
4
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
+$8.16M
5
AMZN icon
Amazon
AMZN
+$6.96M

Sector Composition

Rank Sector Weight
1 Technology 9%
2 Industrials 7.49%
3 Financials 7.44%
4 Consumer Discretionary 5.26%
5 Healthcare 3.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPO icon
451
Exponent
EXPO
$3.24B
$31.6K 0.02%
+274
New +$28.7K
PROF
452
Profound Medical
PROF
$269M
$31.5K 0.02%
+3,961
New +$35.8K
WST icon
453
West Pharmaceutical
WST
$24.9B
$31.5K 0.02%
105
-1,130
-91% -$346K
HOG icon
454
Harley-Davidson
HOG
$2.71B
$31.4K 0.02%
+815
New +$29.5K
MO icon
455
Altria Group
MO
$114B
$31.1K 0.02%
610
-10,248
-94% -$518K
NTAP icon
456
NetApp
NTAP
$37.2B
$30.9K 0.02%
+250
New +$31.2K
OTIS icon
457
Otis Worldwide
OTIS
$28.2B
$30.7K 0.02%
+295
New +$28.1K
TDY icon
458
Teledyne Technologies
TDY
$32B
$30.6K 0.02%
+70
New +$29K
IJK icon
459
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
$30.3K 0.02%
+330
New +$29.5K
APLS
460
DELISTED
Apellis Pharmaceuticals
APLS
$30.3K 0.02%
+1,050
New +$38.9K
SAIA icon
461
Saia
SAIA
$9.72B
$30.2K 0.02%
+69
New +$29.2K
NBIX icon
462
Neurocrine Biosciences
NBIX
$16.6B
$30K 0.02%
+260
New +$35.6K
EQT icon
463
EQT Corp
EQT
$32.3B
$29.9K 0.02%
+815
New +$27.7K
ABNB icon
464
Airbnb
ABNB
$107B
$29.7K 0.02%
+234
New +$30.3K
TARS icon
465
Tarsus Pharmaceuticals
TARS
$2.84B
$29.6K 0.02%
+900
New +$25.3K
CARR icon
466
Carrier Global
CARR
$52.8B
$29.2K 0.02%
+363
New +$25.3K
ENPH icon
467
Enphase Energy
ENPH
$5.53B
$29.2K 0.02%
258
-3,176
-92% -$355K
PAGP icon
468
Plains GP Holdings
PAGP
$4.9B
$28.4K 0.01%
1,533
-8,702
-85% -$165K
OCUL icon
469
Ocular Therapeutix
OCUL
$2.02B
$28.3K 0.01%
+3,250
New +$26.8K
VRSK icon
470
Verisk Analytics
VRSK
$25B
$28.1K 0.01%
+105
New +$28.4K
XYL icon
471
Xylem
XYL
$28.1B
$27.9K 0.01%
+207
New +$27.7K
CNTA
472
DELISTED
Centessa Pharmaceuticals
CNTA
$27.2K 0.01%
+1,700
New +$20.8K
DT icon
473
Dynatrace
DT
$14.2B
$27K 0.01%
+505
New +$24K
CRWD icon
474
CrowdStrike
CRWD
$218B
$26.9K 0.01%
384
-4,600
-92% -$327K
KEY icon
475
KeyCorp
KEY
$24.4B
$26.9K 0.01%
+1,606
New +$25.5K

Similar funds

Golden State Equity Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Golden State Equity Partners held 918 positions worth $190M, down 60% from $480M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Golden State Equity Partners withdrew a net $305M in Q3 2024, closing 104 positions and reducing 253 holdings. Its most notable exit was WisdomTree Floating Rate Treasury Fund, an estimated $4.86M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9% of assets, down from 23% a quarter earlier, followed by Industrials and Financials.

Against the trend, Golden State Equity Partners opened a new position in Automatic Data Processing worth $488K.

  • Golden State Equity Partners's largest Q3 2024 buy was Automatic Data Processing: 1,765 shares worth $488K.
  • Golden State Equity Partners added most to WisdomTree Trust WisdomTree US Quality Dividend Growth Fund in Q3 2024, an estimated $1.51M increase.
  • Golden State Equity Partners's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $27.9M.
  • Golden State Equity Partners fully exited WisdomTree Floating Rate Treasury Fund in Q3 2024, selling an estimated $4.86M.
  • Golden State Equity Partners's ten largest holdings make up 31% of its $190M portfolio in Q3 2024.
  • Golden State Equity Partners opened 505 new positions and closed 104 in Q3 2024.
  • Golden State Equity Partners's portfolio value fell 60% quarter-over-quarter to $190M.

Based on Golden State Equity Partners's 13F filing for Q3 2024, filed 25 Oct 2024.